THE global leader in  blood management solutions for our customers

2018 Press Releases

Webcast ImageWebcast
Haemonetics 2017 Investor Day (Replay)
06/19/17 at 11:00 a.m. ET
Haemonetics 2017 Investor Day
Monday, June 19, 2017 11:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Q4 2018 Haemonetics Corporation Earnings Conference Call (Live)
05/08/18 at 8:00 a.m. ET
Q4 2018 Haemonetics Corporation Earnings Conference Call
Tuesday, May 8, 2018 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
Apr. 10, 2018Haemonetics Sets Date for Publishing Fourth Quarter Fiscal 2018 Results: May 8, 2018
BRAINTREE, Mass., April 10, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish fourth quarter fiscal 2018 financial results at 6:00 am EST on Tuesday, May 8, 2018. The Company will hold a webcast conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on May 8, 2018.  Webcast Link: https://edge.media-server.com/m6/p/wcre57f8https://edge.media-server.com/m6/p/qyrbnno... 
Printer Friendly Version
Mar. 28, 2018Haemonetics Announces Regulatory Clearances of NexSys PCS™ Enhanced Software with YES™ Technology
Embedded Software Adds Key Capability to NexSys PCS Platform BRAINTREE, Mass., March 28, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for enhancement of its NexSys PCS™ embedded software. This capability activates the YES™ technology, a yield enhancing solution enabling increases in plasma yield per collection.   This 510(k) cleared by FDA includes the following in... 
Printer Friendly Version
Feb. 06, 2018Haemonetics 3rd Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website
Financial release accessible online BRAINTREE, Mass., Feb. 6, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that third quarter and year-to-date fiscal 2018 financial results are available on its Investor relations website. The Company is posting this press release and, additionally, results tables that will be referenced on its webcast to its Investor Relations website.  Direct link to Earnings Release 3Q and YTD FY18: http:... 
Printer Friendly Version
Jan. 25, 2018Ellen M. Zane Rejoins Haemonetics Board of Directors
BRAINTREE, Mass., Jan. 25, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the election of Ellen M. Zane to its Board of Directors. Zane is a nationally renowned health care leader with more than 30 years of experience in hospitals and health care systems. Zane led the turnaround of Tufts Medical Center and Floating Hospital for Children in Boston, where she retired as President and Chief Executive Officer in 2011 and currently serves as Vi... 
Printer Friendly Version